share_log

4: Statement of changes in beneficial ownership of securities-Officer Dogan Meeshanthini

4: Statement of changes in beneficial ownership of securities-Officer Dogan Meeshanthini

4:持股變動聲明-高管 Dogan Meeshanthini
美股SEC公告 ·  2024/09/09 23:10

Moomoo AI 已提取核心訊息

Cardio Diagnostics Holdings, Inc. (CDIO) reported that its Chief Technology Officer, Dogan Meeshanthini, completed a purchase of company stock on September 6, 2024. The transaction involved the acquisition of 68,965 shares of common stock at a price of $0.29 per share. Following this transaction, Meeshanthini's direct holdings in the company increased to a total of 197,310 shares. The purchase, conducted on the open market, reflects a vote of confidence in the company's prospects by a key executive.
Cardio Diagnostics Holdings, Inc. (CDIO) reported that its Chief Technology Officer, Dogan Meeshanthini, completed a purchase of company stock on September 6, 2024. The transaction involved the acquisition of 68,965 shares of common stock at a price of $0.29 per share. Following this transaction, Meeshanthini's direct holdings in the company increased to a total of 197,310 shares. The purchase, conducted on the open market, reflects a vote of confidence in the company's prospects by a key executive.
Cardio Diagnostics Holdings, Inc. (CDIO)報告稱,其首席技術官Dogan Meeshanthini於2024年9月6日完成了對公司股票的購買。該交易涉及以0.29美元的價格收購68965股普通股。在此交易之後,Meeshanthini在公司的直接持股增加至總共197310股。這次在公開市場上進行的購買反映了公司高管對公司前景的信心。
Cardio Diagnostics Holdings, Inc. (CDIO)報告稱,其首席技術官Dogan Meeshanthini於2024年9月6日完成了對公司股票的購買。該交易涉及以0.29美元的價格收購68965股普通股。在此交易之後,Meeshanthini在公司的直接持股增加至總共197310股。這次在公開市場上進行的購買反映了公司高管對公司前景的信心。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息